Kathleen M. Boozang
Kathleen Boozang has been Dean of Seton Hall Law since July 2015. She has served in multiple administrative capacities during her tenure at Seton Hall, including Associate Dean for Academic Affairs for eight years and Vice Provost for two years.
Dean Boozang came to Seton Hall in 1990 as the founder of the Law School’s now top-ranked Center for Health & Pharmaceutical Law & Policy. Prior to becoming Dean, she also established the Law School’s graduate degrees, Division of Online Learning and global life sciences compliance training programs.
Dean Boozang teaches a variety of health law courses in person and online including the survey health law course, a course on health care fraud and corruption, and death and dying. In her scholarship, Dean Boozang has dedicated much of her career to nonprofit governance issues with a special focus on religiously sponsored hospitals. In the last several years, however, she has expanded her research and teaching to explore the legal and policy issues related to corporate compliance, with a particular focus on the global life sciences industry.
Dean Boozang is a Fellow of The Hastings Center, an independent nonprofit bioethics research institute, as well as a Fellow of the American Bar Foundation, an honorary organization of legal practitioners. She is also a member of the American Law Institute and participates on the consultant groups for the Principles of Nonprofit Law and Corporate Compliance. She serves on the Editorial Board of the Journal of Health and Life Sciences Law and is a past editor-in-chief of the Journal of Law, Medicine & Ethics. She is past president of the American Society of Law, Medicine & Ethics (ASLME) and also previously sat on the Advisory Board of the Journal of Health Law. Dean Boozang served for many years on the Board of Directors of the American Health Lawyers Association (AHLA), and remains involved in many AHLA projects.
Throughout her legal career, Dean Boozang has been active in public service. She has served on numerous advisory boards and committees for healthcare providers and for the states of New Jersey and New York, including serving as an advisor to the New Jersey Attorney General Task Force on Physician Compensation by Pharmaceutical Companies, which resulted in the promulgation of proposed regulation. She is a former member of the New York State Task Force on Life and the Law, an interdisciplinary commission with a mandate to develop public policy on bioethical issues.
Dean Boozang currently serves on the Board of Trustees of the St. Joseph Healthcare System in New Jersey. In 2013, the ASLME conferred upon Dean Boozang the Jay Healy Health Law Teacher Award. She was named the Seton Hall University Woman of the Year in 2006 and the Washington University Law School’s Young Alum of the Year in 2004. She graduated from Washington University School of Law in St. Louis, Missouri, where she was inducted into the Order of the Coif and served as the managing editor of Law Quarterly. She received her LL.M. from Yale Law School in 1990.
BOOKS AND BOOK CHAPTERS
Legal and Ethical Issues in Complemantary and Alternative Medicine, in John Spencer & Joe Jacobs, Complementary and Alternative Medicine: An Evidence Based Approach, Spencer & Jacobs (2003)
Problems and Conflicts Between Law and Morality in a Free Society, in Is There a Right to Life at the End of Life?, (James E. Wood & Derek Davis) (1994)
LAW REVIEW ARTICLES
Responsible Corporate Officer Doctrine: When is Falling Down on the Job a Crime?, 6 J. Health L & Pol'Y 77 (2012)
"Monitoring" Corporate Corruption: DOJ's Use of Deferred Prosecution Agreements in Health Care, 35 Am. J.L. Med. 89 (Spring 2009) (with Simone Handler-Hutchinson)
A Civil Law Analysis: The Place of Religion in Treatment Termination Decision-Making, Temple Political and Civil Rights L. Rev. (2007)
Does Director Independence Improve Nonprofit Governance?, 75 Tenn. L. Rev. 83 (2007)
Mission, Margin and Trust in the Nonprofit Healthcare Enterprise, 5 Yale J. Health Pol’y, L. and Ethics 1 (2005) (T.L. Greaney)
Therapeutic Placebos: Making the Case for Patient Deception, 54 Fla. L. Rev. 687 (2002)
CAM for Kids, 1 Houston J. Health L. & Pol'y 109 (2001)
An Intimate Passing: Restoring the Role of Family and Religion in Dying, 58 U. Pitt. L. Rev. 549 (1997)
The Survival of Religious Hospitals in a World of Reformed Health Care, 31 Houston L. Rev. 1429 (1995)
OTHER JOURNAL ARTICLES
The New Relator: In-House Counsel and Compliance Officers, J. H & Life Sciences L. (2012)
Toward Evidence-Based Conflicts of Interest Training for Physician-Investigators, J L Med Ethics (2012) (with Carl Coleman and Kate Greenwood)
Transparency: It May Not Be Sufficient, 4 Life Science Compliance 14 (2012)
An Argument Against Embedding Conflicts of Interest Disclosures in Informed Consent, 4 J.H. & Life Sciences L. 230 (2011) (with Carl H. Coleman and Kate Greenwood)
A New Pathway to Market for Biosimilars, 4 J. H & Life Sciences L. 121 (2010) (with Judith Toffentti)
Board Independence and Transparency: Searching for the Key to Good Governance, 1 J. Health & Life Sci. L. 127 (2009)
Independence and Transparency: Keys to Good Corporate Governance, 1 J. Health & Life Sciences L. 127 (2008)
National Policy on CAM: The White House Commission Report, 31 J.L. Med. & Ethics 251 (2003)
Reconciling Health Care Needs and Religious Practices, 5 Gov't L. & Pol'Y J. 23 (2003)
Western Medicine Opens the Door to Alternative Medicine, XXIV J. Law & Med. 185 (1998)
Developing a Public Policy Toward the Sectarian Provider: Accommodating Religious Beliefs and Obtaining Patient Access to Care, 24 J. Law, Medicine & Ethics 89 (1996)
Symposium: Is a For-Profit Structure a Viable Alternative for a Health Care Ministry?, Center for Religiously Affiliated Nonprofit Corporations & Center for Health & Pharmaceutical Law & Policy (2013) (In collaboration with University of St. Thomas)
The Limits of Disclosure as a Response to Financial Conflicts of Interest in Clinical Research, (2010) (A White Paper by The Center for Health & Pharmaceutical Law & Policy) (collaborator)
Conflicts of Interest in Clinical Trial Recruitment & Enrollment: A Call for Increased Oversight, (2009) (A White Paper by The Center for Health & Pharmaceutical Law & Policy) (collaborator)
Drug and Device Promotion: Charting A Course for Policy Reform, (2009) (A White Paper by The Center for Health & Pharmaceutical Law & Policy) (collaborator)
Case Study: The Abuse of Alternative Medicine?, 33 Hastings Center Rptr. 13-14 (2003)
AHLA Pharmaceutical and Medical Device Compliance Manual, First Ed. (2012) (with Simone Handler-Hutchinson)
The Aspirations and Challenges of Decision Aids, Arizona Syllabus (Spring 2013)
The Best Of... A Health Law Reader: An Interdisciplinary Approach, 21 J. L. MED. 593 (Winter 2001)
WORKS IN PROGRESS
In Defense of the Responsible Corporate Officer Doctrine
Full list of presentations available in Curriculum Vitae
Annual Flora Barlotta Lecture: End of Life Care, (Spring 2011) (Saint Barnabas Medical Center)
U.S. Waste Fraud and Abuse Laws, E.U. Corporate Compliance Program (June 2011) (Paris, France)